Cargando…
Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology”
Autores principales: | Speeckaert, Reinhart, Lambert, Jo, Puig, Lluís, Speeckaert, Marijn, Lapeere, Hilde, De Schepper, Sofie, van Geel, Nanja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7965843/ https://www.ncbi.nlm.nih.gov/pubmed/33744352 http://dx.doi.org/10.1016/j.jaad.2021.03.038 |
Ejemplares similares
-
Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies?
por: Speeckaert, Reinhart, et al.
Publicado: (2021) -
Hypomelanoses in Children
por: van Geel, Nanja, et al.
Publicado: (2013) -
Response to comment on “An evidence-based guide to SARS-Cov-2 vaccination of patients on immunotherapies in dermatology.”
por: Gresham, Louise M., et al.
Publicado: (2021) -
The Meaning and Reliability of Minimal Important Differences (MIDs) for Clinician-Reported Outcome Measures (ClinROMs) in Dermatology—A Scoping Review
por: Speeckaert, Reinhart, et al.
Publicado: (2022) -
Autoimmunity in Segmental Vitiligo
por: Speeckaert, Reinhart, et al.
Publicado: (2020)